Macular Degeneration Treatment Market To Surpass $ 21.1 Billion By 2031: TMR Study

  • The tremendous need for effective treatments for age-related wet macular degeneration presents vast value acquisition opportunities for companies in the macular degeneration treatment market; increasing adoption of anti-VEGF drugs for age-related macular degeneration (AMD) that fuel revenue generation
  • Europe market to expand at promising rates, spurred by the launch of new products; huge demand for care in hospitals, especially in the elderly

WILMINGTON, Del., September 21, 2022 / PRNewswire / – The increased demand for age-related wet macular degeneration treatments has generated substantial revenue streams in the market over the years. The segment was the largest revenue generator in the macular degeneration treatment market in 2021 and is expected to expand rapidly during the forecast period. The growing burden of retinal disorders has spurred demand for products in the macular degeneration treatment market. The size of the global market is estimated to exceed 21.1 billion dollars by 2031.

Get Exclusive PDF Sample Copy Of Macular Degeneration Treatment Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=60645

Recent developments in the macular degeneration treatment market underscore that key players are leaning on the development of long-acting anti-VEGFs to gain significant revenue shares. The high burden of age-related macular degeneration (AMD), which hinges on the rapidly aging population in industrialized nations, underlies the enormous income potential.

The growing awareness of the effectiveness of intravitreal injections (IVT) for wet AMD has driven the generation of revenue in the macular degeneration treatment market. Many leading players in the macular degeneration treatment market are actively involved in increasing the safety and efficacy of antivascular endothelial growth factor therapies. Vascular endothelial growth factor (VEGF) research and development will therefore create profitable future market demand for the treatment of macular degeneration.

Request References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=60645

Key Findings from the Macular Degeneration Treatment Market Study

  • Abundant demand for therapies for the management of wet age-related macular degeneration: The massive demand for treatments for wet (exudative or neovascular) age-related macular degeneration is spurring market growth. Wet AMD is a leading cause of visual impairment in the elderly and therefore presents a broad avenue. The increase in the number of FDA injections approvals has strengthened the growth prospects of the macular degeneration treatment market. Wet AMD presents the fastest growing market for the treatment of macular degeneration. Meanwhile, the study authors found that adopting treatments for age-related macular degeneration (AMD) drives huge revenue streams. Players are launching new drugs to gain a competitive edge over others.
  • Massive demand for hospital treatment: Developed countries are seeing a high prevalence of AMD. It should be noted that the diagnosis of new cases of AMD in hospitals has fueled the need for treatments for macular degeneration. The hospital segment is expected to account for the majority of the share by the end of 2031.

Macular Degeneration Treatment Market: Key Factors

  • The growing awareness of the prevalence and burden of age-related macular degeneration, especially in developed countries, is a key driver of the macular degeneration treatment market. In patients over the age of 60, AMD is one of the most common causes of vision loss and vision disturbances.
  • Increasing research and development on vascular endothelial growth factor (VEGF) has contributed to the development of more effective therapies, thus broadening the avenues in the market for the treatment of macular degeneration. The increase in the prevalence of retinal disorders with age is a key trend that presents untapped revenue potential for market players.

Make a request before buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=60645

Macular Degeneration Treatment Market: Regional Growth Dynamics

  • North America held a significant share of the global macular degeneration treatment market in 2021. The substantial product adoption rate in the United States generated considerable profitable opportunities. In addition, the increase in product launches in the United States has also strengthened revenue streams.
  • Europe it holds a key market share in 2021 and is expected to expand at a rapid pace during the forecast period 2022-2031. Widespread demand for brand name drugs and the introduction of new macular degeneration drugs are reinvigorating the growth prospects of the Europe market for the treatment of macular degeneration.
  • Asia Pacific is a profitable region in the macular degeneration treatment market. The growing diagnosis of AMD has catalysed the need for treatment.

Macular Degeneration Treatment Market: Competition Landscape

The presence of numerous major players vying for a significant share of the global market makes the competitive landscape highly fragmented. Some of the major players are Santen Pharmaceutical Co., Ltd., Novartis AG, Regeneron Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Pfizer, Inc., and AbbVie, Inc.

Macular Degeneration Treatment Market Segmentation

  • Disease indication
    • Age-related wet macular degeneration
    • Macular degeneration linked to dry age
    • Other
  • Drug class
    • Antivascular endothelial growth factor
    • Other
  • Distribution channel
    • Hospitals
    • Ophthalmology clinics
    • Outpatient Surgical Centers

Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Modernization of healthcare in terms of both infrastructure and services has pushed the healthcare sector to new levels, Stay up to date with Latest Health Research Reports from market research on transparency:

Skin Care Serums Market: The global skin care serums market is expected to reach more than 6.28 billion dollars by the end of 2031 with a CAGR of 7.4% from 2022 to 2031.

Epilepsy Therapies Market: The global epilepsy therapies market is expected to reach more than 14.9 billion dollars by the end of 2031.

Vitamin D Test Market: The global vitamin D test market is expected to reach more than 1.06 billion US dollars by the end of 2031 with a CAGR of 5.8% from 2022 to 2031.

Laboratory Gas Generator Market: The global laboratory gas generator market is expected to reach more than 1.27 billion US dollars by the end of 2031 with a CAGR of 11.0% from 2022 to 2031.

Bruising Treatment Market: The global bruising treatment market is expected to reach more than 444 million US dollars by the end of 2031 with a CAGR of 3.5% from 2022 to 2031.

Substance Abuse Treatment Market: The global substance abuse treatment market is expected to cross 23.1 billion dollars by 2031 with a CAGR of 8.5% from 2022 to 2031.

Chronic Pelvic Pain Treatment Market: The global chronic pelvic pain treatment market is expected to reach more than 8 billion dollars by the end of 2031 with a CAGR of 3.6% from 2022 to 2031.

Psoriasis Treatment Market: The global psoriasis treatment market is expected to reach more than 44 billion dollars by the end of 2031 with a CAGR of 8.7% from 2022 to 2031.

Information on transparency market research

Transparency Market Research, a global market research firm registered in Wilmington, Delaware, United States, provides customized research and consultancy services. Our unique combination of quantitative forecasting and trend analysis provides forward-looking insights to thousands of decision makers. Our expert team of analysts, researchers and consultants use proprietary data sources and various tools and techniques to collect and analyze information.

Our data repository is continually updated and reviewed by a team of research experts, so that it always reflects the latest trends and information. With extensive research and analytical capabilities, Transparency Market Research uses rigorous primary and secondary research techniques in developing distinctive datasets and research material for corporate reporting.

For more insights into leading industry research, visit our YouTube channel and rewards subscribe for future update – https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact
Rohit Bhisey
Transparency Market Research Inc.
CITY CENTER COMPANY HEADQUARTERS,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 United States
Tel: + 1-518-618-1030
United States of America – Canadian Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
E-mail: [email protected]

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg

SOURCE Market research on transparency

    .

Leave a Reply

%d bloggers like this: